학술논문
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
Document Type
Article
Author
Modjarrad, K.; Lin, L.; Eckels, K.H.; De La Barrera, R.A.; Jarman, R.G.; Sondergaard, E.; Mills, K.; Koren, M.; Thomas, S.J.; Michael, N.L.; George, S.L.; Tennant, J.; Meyer, K.E.; Blazevic, A.; Mosby, K.; Hoft, D.F.; Brien, J.; Stephenson, K.E.; Ansel, J.L.; Tan, C.S.; Walsh, S.R.; Larocca, R.A.; Abbink, P.; Boyd, M.; Bricault, C.A.; Seaman, M.S.; Barouch, D.H.; Robb, M.L.; Crowell, T.A.; Basil, A.; Walsh, M.; Tonwe, V.; Barrett, J.; Thompson, J.; Kosel, A.E.; Dawson, P.; Hale, A.
Source
In: The Lancet . (The Lancet, 10 - 16 February 2018, 391(10120):563-571)
Subject
Language
English
ISSN
1474547X
01406736
01406736